[go: up one dir, main page]

WO1996016016A1 - Nouveaux derives d'acide (+)-(s)-2-(3-benzoylphenyl)propionique a action analgesique et procedes de preparation - Google Patents

Nouveaux derives d'acide (+)-(s)-2-(3-benzoylphenyl)propionique a action analgesique et procedes de preparation Download PDF

Info

Publication number
WO1996016016A1
WO1996016016A1 PCT/EP1995/004554 EP9504554W WO9616016A1 WO 1996016016 A1 WO1996016016 A1 WO 1996016016A1 EP 9504554 W EP9504554 W EP 9504554W WO 9616016 A1 WO9616016 A1 WO 9616016A1
Authority
WO
WIPO (PCT)
Prior art keywords
salt
compound
lysine
propionic acid
glucamine
Prior art date
Application number
PCT/EP1995/004554
Other languages
English (en)
Inventor
David Mauleon Casellas
María Luisa GARCIA PEREZ
María de los Desamparados FOS TORRO
Original Assignee
Laboratorios Menarini S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Menarini S.A. filed Critical Laboratorios Menarini S.A.
Priority to AU39835/95A priority Critical patent/AU3983595A/en
Publication of WO1996016016A1 publication Critical patent/WO1996016016A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings

Definitions

  • (+)-(S) enantiomer of ketoprofen has been claimed to be a faster acting and more potent analgesic than the race ate, when administered at equal doses [Sunshine A. et al., WO 89/04658].
  • Structurally ketoprofen similarly to other arylpropionic acids, has a lipophilic aromatic moiety which is responsible for its poor solubility in water and a free carboxylic group which has been related to its ulcerogenic toxicity.
  • arylpropionic acids may substantially be overcome by salifying them with metals, to give salts such as ketoprofen sodium, zinc or aluminium salt [Fuji ura H. et al., Oyo Yakuri , 1-2, 709 (1977), Buxad ⁇ A. ES 2016503, Montanari R. DE 3505582, respectively]; with basic amino acids such as ibuprofen [Kwan K.Ch. EP 424028] and ketoprofen [Metz G. EP 136470, BE 882889, Bruzzese T.
  • the present invention provides a series of novel compounds showing the cited anti-inflammatory and analgesic actions, together with a very reduced gastrolesivity.
  • the novel salts have a high solubility in water which allows for them to be administered both intramuscularly and intravenously, as well as orally in the form of tablets which are easy to dissolve in a very short time.
  • These novel derivatives exhibit a fast, complete adsorption both in animals and humans, showing an action and analgesic response higher than those of the corresponding racemic ketoprofen salts.
  • said characteristics of the compounds of the present invention allow to attain the same analgesic therapeutical effectiveness using doses lower than those necessary for racemic ketoprofen, either free or salified. Further, the physico-chemical and phar acokinetic properties of the compounds of the present invention give them a therapeutical advantage compared with the use of the (+)-(S) enantiomer of ketoprofen in the free acid form, claimed in the above cited patent [Sunshine A.
  • B + is choline or the protonated form of lysine, arginine, ornithine, D-glucamine, N-methyl-D-glucamine or imidazole.
  • the present invention also provides a process for the preparation of the novel (+)-(S)-2-(3-benzoyl- phenyl)propionic acid salts, as well as the therapeutical use thereof.
  • Object of the present invention are also the solvates of the compounds of formula (I).
  • the present invention also includes all the possible stereoisomers of the compounds of formula (I) as well the mixtures thereof.
  • Preferred compounds of the present invention are those wherein B + is choline or the protonated form of
  • N-methyl-D-glucamine or imidazole N-methyl-D-glucamine or imidazole.
  • Particularly preferred compounds of the present invention are the following ones:
  • the compounds of formula (I) are obtained by reacting (+)- (S)-2-(3-benzoylphen ⁇ l)propionic acid (II)
  • a mixture of water with methanol or ethanol is used and, when employing the sodium salt of the compound of formula (II), ethanol or isopropanol with a low water content are preferably used to promote the precipitation of sodium chloride formed during the reaction.
  • the reaction temperature can vary between 0 * C and the solvent reflux, for a time between 1 and 24 hours.
  • the compounds of the present invention have anti- inflammatory and analgesic characteristics and therefore they can be used in human therapy.
  • the compounds of the present invention are formulated in suitable pharmaceutical forms, according to conventional techniques and excipients, such as those described in Remington's Phramaceutical Handbook, Mack Pub. Co., N.Y., USA.
  • suitable pharmaceutical forms include capsules, tablets, granulates, solutions, syrups and the like, containing 1 to 1000 g per unitary dose.
  • (+)-(S)-2-(3-Benzoylphenyl)propionic acid was reacted with DL-lysine analogously to what described in Example 1.
  • a water-soluble white solid was obtained.
  • (+)-(S)-2-(3-benzoylphenyl)propionic acid 2.0 g, 7.87 mmol
  • the mixture was heated to 60"C for 10 hours, thereafter was evaporated to dryness, to obtain a semi-solid residue which was redissolved in ethanol and evaporated to dryness.
  • the resulting solid was filtered and washed with ethyl ether. 2.52 g (89%) of a white solid were obtained. Elemental analysis: calculated for C 21 H 2 NO: C, 70.56%; H, 7.61%; N, 3.92%. Found: C, 70.12%; H, 7.31%; N, 3.62%.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

On décrit de nouveaux sels d'acide (+)-(S)-2-(3-benzoylphényl) propionique de formule (I), où B+ représente choline ou la forme protonée de lysine, arginine, ornithine, D-glucamine, N-méthyl-D-glucamine ou imidazole. Leur procédé de préparation consiste à faire réagir un composé de formule (II) avec lysine, arginine, ornithine, hydroxyde de choline, D-glycamine, N-méthyle-D-glucamine ou imidazole, ou bien à faire réagir un sel du composé de formule (II) avec le sel organique approprié. Ces composés présentent une activité analgésique et anti-inflammatoire élevée.
PCT/EP1995/004554 1994-11-23 1995-11-20 Nouveaux derives d'acide (+)-(s)-2-(3-benzoylphenyl)propionique a action analgesique et procedes de preparation WO1996016016A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU39835/95A AU3983595A (en) 1994-11-23 1995-11-20 Novel (+)-(s)-2-(3-benzoylphenyl)propionic acid derivatives with analgesic action and the process for the preparation thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES9402406A ES2109858B1 (es) 1994-11-23 1994-11-23 Nuevos derivados del acido (+)-(s)-2-(3-benzoilfenil) propionico con accion analgesica y procedimiento para su obtencion.
ESP9402406 1994-11-23

Publications (1)

Publication Number Publication Date
WO1996016016A1 true WO1996016016A1 (fr) 1996-05-30

Family

ID=8288066

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1995/004554 WO1996016016A1 (fr) 1994-11-23 1995-11-20 Nouveaux derives d'acide (+)-(s)-2-(3-benzoylphenyl)propionique a action analgesique et procedes de preparation

Country Status (3)

Country Link
AU (1) AU3983595A (fr)
ES (1) ES2109858B1 (fr)
WO (1) WO1996016016A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2315763A (en) * 1996-07-31 1998-02-11 Procter & Gamble Preparation of an agglomerated detergent composition comprising a surfactant a an acid source
WO1999052528A1 (fr) * 1998-04-11 1999-10-21 Errekappa Euroterapici S.P.A. Preparations pharmaceutiques a base de sels de ketoprofene hydrosoluble et applications correspondantes
JP2009513613A (ja) * 2005-10-28 2009-04-02 フルニエ ラボラトリーズ アイルランド リミテッド 酸と第四級アンモニウムとの塩を調製するための新規な方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5179097A (en) * 1991-06-10 1993-01-12 Angres Isaac A Salts of non-steroidal anti-inflammatory carboxylic acids and anti-lipidemic carboxylic acids
WO1994020449A1 (fr) * 1993-03-09 1994-09-15 Dompe'farmaceutici Spa Sels d'acide 2-(3-benzoylphenyl)propionique et de bases organiques chirales ou achirales, et compositions pharmaceutiques les contenant

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5179097A (en) * 1991-06-10 1993-01-12 Angres Isaac A Salts of non-steroidal anti-inflammatory carboxylic acids and anti-lipidemic carboxylic acids
WO1994020449A1 (fr) * 1993-03-09 1994-09-15 Dompe'farmaceutici Spa Sels d'acide 2-(3-benzoylphenyl)propionique et de bases organiques chirales ou achirales, et compositions pharmaceutiques les contenant

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2315763A (en) * 1996-07-31 1998-02-11 Procter & Gamble Preparation of an agglomerated detergent composition comprising a surfactant a an acid source
WO1999052528A1 (fr) * 1998-04-11 1999-10-21 Errekappa Euroterapici S.P.A. Preparations pharmaceutiques a base de sels de ketoprofene hydrosoluble et applications correspondantes
US6291527B1 (en) 1998-04-11 2001-09-18 Errekappa Euroterapici S.P.A. Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application
JP2009513613A (ja) * 2005-10-28 2009-04-02 フルニエ ラボラトリーズ アイルランド リミテッド 酸と第四級アンモニウムとの塩を調製するための新規な方法
US7714163B2 (en) 2005-10-28 2010-05-11 Fournier Laboratories Ireland Ltd. Process for preparing quaternary acid and ammonium salts

Also Published As

Publication number Publication date
ES2109858A1 (es) 1998-01-16
AU3983595A (en) 1996-06-17
ES2109858B1 (es) 1998-08-16

Similar Documents

Publication Publication Date Title
US5554789A (en) Arylpropionic derivative, a process for the preparation and the use thereof as an analgesic agent
EP0082088B1 (fr) Nouveaux dérivés d'aminoacides, et leur application thérapeutique
HK1006306B (en) A novel arylpropionic derivative, a process for the preparation and the use thereof as an analgesic agent
WO1996016016A1 (fr) Nouveaux derives d'acide (+)-(s)-2-(3-benzoylphenyl)propionique a action analgesique et procedes de preparation
KR100224330B1 (ko) 골관절 질환의 치료에 유용한 n-((4,5-디히드록시-및 4,5,8-트리히드록시-9,10-디히드로-9,10-디옥소-2-안트라센-일)카르보닐)아미노산
IE47073B1 (en) Alpha amino-acids, compositions and process for preparing said compounds
JPS6351135B2 (fr)
ZA200005589B (en) 2-methylpropionic acid derivatives and medicinal compositions containing the same.
WO1996016017A1 (fr) Nouveaux derives arylpropioniques possedant une action analgesique et leur procede de preparation
US4034100A (en) Antihypertensive agents
CN101906069A (zh) (s)-2-取代-(3’-乙酰基-2’-吡啶酮-1’-基)乙酸及其制备方法和应用
TWI223647B (en) Crystalline polymorph of aminoethylphenoxyacetic acid derivative
FR2604434A1 (fr) Derives d'amino-2 ethanethiol, leur preparation et leur application en therapeutique
KR810001274B1 (ko) 페닐글리신 유도체의 제조방법
CN116903465A (zh) 一种阿魏酸修饰的丁苯酞开环衍生物及其制备方法与应用
JP2000212137A (ja) アミノエチルフェノキシ酢酸誘導体二水和物の結晶多形
JPH11503131A (ja) 新規の複素環化合物
FR2505328A1 (fr) N-(4-(3-aminopropyl) aminobutyl)-2,2-dihydroxyethanamide et procede pour sa preparation
JPH068267B2 (ja) Ｎ，ｎ−二置換フエニルセリン誘導体及びそれを有効成分とする中枢神経系用剤
JP2000212139A (ja) アミノエチルフェノキシ酢酸誘導体の結晶多形
JPH05221940A (ja) サリチロイル−カルニチンおよびその製造方法
JP2000212138A (ja) アミノエチルフェノキシ酢酸誘導体二水和物の結晶多形
JPH0551377A (ja) 光学活性ジベンゾチエピン酸の製造法
SK280172B6 (sk) Salicyloylkarnitín a spôsob jeho výroby
FR2646853A1 (fr) Nouveaux derives polypeptidiques d'aminophenylpyridazinones, leurs procedes de preparation, medicaments les contenant, utiles notamment pour le traitement des maladies cardiovasculaires

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MX NO NZ PL PT RO RU SE SG SI SK TJ TM TT UA US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA